Publicacións en colaboración con investigadores/as de Pfizer (United States) (5)

2024

  1. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

    European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

  2. The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary

    Future Cardiology

2020

  1. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

2014

  1. Sirolimus conversion after heart transplant: Risk factors for acute rejection and predictors of renal function response

    American Journal of Transplantation, Vol. 14, Núm. 9, pp. 2048-2054

2012

  1. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency

    American Journal of Transplantation, Vol. 12, Núm. 9, pp. 2487-2497